FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

763651005: Benralizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3643176013 Benralizumab en Synonym Active Entire term case insensitive SNOMED CT core module
3643177016 Benralizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benralizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Benralizumab Is a Substance with interleukin receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Benralizumab Has disposition Interleukin receptor antagonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing benralizumab Has active ingredient True Benralizumab Inferred relationship Existential restriction modifier 1
Product containing benralizumab in parenteral dose form (medicinal product form) Has active ingredient True Benralizumab Inferred relationship Existential restriction modifier 1
Benralizumab Has active ingredient True Benralizumab Inferred relationship Existential restriction modifier 1
Product containing only benralizumab in parenteral dose form (medicinal product form) Has active ingredient True Benralizumab Inferred relationship Existential restriction modifier 1
Product containing precisely benralizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Benralizumab Inferred relationship Existential restriction modifier 1
Product containing precisely benralizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Benralizumab Inferred relationship Existential restriction modifier 1
Benralizumab 30mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Benralizumab 30mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Fasenra 30mg/1ml solution for injection pre-filled pens (AstraZeneca UK Ltd) Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Fasenra 30mg/1ml solution for injection pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Benralizumab 30mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Benralizumab 30mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Fasenra 30mg/1ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier
Fasenra 30mg/1ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Benralizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start